MeiraGTx Holdings Plc (MGTX)
13.82
-0.32
(-2.26%)
USD |
NASDAQ |
Aug 28, 16:00
13.82
0.00 (0.00%)
After-Hours: 20:00
MeiraGTx Holdings Price to Book Value : 6.038 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 6.038 |
| August 27, 2026 | 6.178 |
| August 26, 2026 | 6.362 |
| August 25, 2026 | 6.519 |
| August 24, 2026 | 6.480 |
| August 21, 2026 | 6.266 |
| August 20, 2026 | 6.353 |
| August 19, 2026 | 6.541 |
| August 18, 2026 | 6.069 |
| August 17, 2026 | 6.016 |
| August 14, 2026 | 5.907 |
| August 13, 2026 | 5.536 |
| August 12, 2026 | 5.662 |
| August 11, 2026 | 5.702 |
| August 10, 2026 | 5.689 |
| August 07, 2026 | 5.711 |
| August 06, 2026 | 5.588 |
| August 05, 2026 | 5.483 |
| August 04, 2026 | 5.370 |
| August 03, 2026 | 5.191 |
| July 31, 2026 | 5.151 |
| July 30, 2026 | 5.234 |
| July 29, 2026 | 5.077 |
| July 28, 2026 | 5.164 |
| July 27, 2026 | 5.374 |
| Date | Value |
|---|---|
| July 24, 2026 | 5.143 |
| July 23, 2026 | 5.287 |
| July 22, 2026 | 5.313 |
| July 21, 2026 | 5.470 |
| July 20, 2026 | 5.335 |
| July 17, 2026 | 5.435 |
| July 16, 2026 | 5.387 |
| July 15, 2026 | 5.488 |
| July 14, 2026 | 5.435 |
| July 13, 2026 | 5.392 |
| July 10, 2026 | 5.850 |
| July 09, 2026 | 6.091 |
| July 08, 2026 | 6.178 |
| July 07, 2026 | 6.405 |
| July 06, 2026 | 6.069 |
| July 02, 2026 | 6.082 |
| July 01, 2026 | 5.593 |
| June 30, 2026 | 5.903 |
| June 29, 2026 | |
| June 26, 2026 | |
| June 25, 2026 | |
| June 24, 2026 | |
| June 23, 2026 | |
| June 22, 2026 | |
| June 18, 2026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Xencor, Inc. | 3.849 |
| UroGen Pharma Ltd. | -- |
| IDEAYA Biosciences, Inc. | 3.224 |
| ACADIA Pharmaceuticals, Inc. | 3.835 |
| Alnylam Pharmaceuticals, Inc. | 23.42 |
Price to Book Value Related Metrics
| PE Ratio | 19.58 |
| PS Ratio | 2.931 |
| Price to Free Cash Flow | 115.83 |
| Price | 13.82 |
| Earnings Yield | 5.11% |
| Market Cap | 1.302B |
| Operating PE Ratio | 6.379 |
| Normalized PE Ratio | 19.92 |